Skip to main content

Deal Alert: Fidelity Growth Partners India Leads an INR 400Crore(US$ 75 million) Investment Round in Trivitron Healthcare Private Limited

From the Press Release:

Trivitron Healthcare Private Limited (Trivitron) announced today that Fidelity Growth Partners India (FGPI) hasanchored a round of investmentof approximately INR 400crores (US$ 75 million).This investment also provides partial exits for ePlanet Ventures and Headland Capital, who have been invested in Trivitron since 2007. 

For the past fifteen years, Trivitronhas been India’s largest exclusive pan India wholesale distributor and after-sales support provider of medical equipment and devices. Its areas of expertise include imaging, lab diagnostics, cardiology, critical care,renal care, operating room and ophthalmology equipment. Trivitron is the partner of choice for anyforeign manufacturer looking to enter the country on account of its strong reputation and track record, national sales-and-service network and robust logistics infrastructure. 

Over the past few years, subsidiaries and joint ventures of Trivitron havebeen steadily laying the foundations for manufacturing medical equipment. Trivitron Medical Technology Park, a 25-acre state-of-the-art manufacturing facility in Chennai, was established in 2009 to house over 15 different medical technology manufacturing facilities of Trivitron’s subsidiaries and joint ventures;Trivitron’s joint ventures with Hitachi-Aloka (Japan) for manufacturing ultrasound equipment and with Biosystems (Spain) for lab diagnostics reagents are already operational.The company has recently set up centres of innovationfor biomedical equipment in collaboration with the Indian Institute of Technology (IIT), Chennai and under the leadership of its Director (R&D), Prof. Bhuvaneshwar, a wellrecognized innovator in this area. 

With the new fund infusion into the company, Trivitron aims to become a global player in the imaging and labdiagnosticssegments through organic growth as well as through acquisition of companies and technologies in Europe and the United States. The funds will be used to increaseTrivitron’s shareholding in Kiran Medical Systems, an international player in imaging accessories, expanding operations at Trivitron Medical Technology Park, and enhancing the company’s distribution operations in South East Asia, Middle East and Africa. 

Trivitron was founded in 1997 by Dr. G.S.K. Velu after his stint as the Country Head for Chiron Diagnostics, before embarking on a successful entrepreneurial journey. In addition to Trivitron, Dr. Velu has co-founded and built the country’s leading path lab chain, Metropolis Healthcare, as well as Medfort, a chain of single specialty, eye-care and diabetes-care hospitals. He has also co-founded a joint venture with the Apollo Hospitals Group for dental clinics(Apollo White) and dialysis centres (Apollo Dialysis). 

Commenting on the transaction, Mr. Raj Dugar, Senior Managing Director at FIL Capital Advisors (India) Private Limited, the private equity advisory arm for FGPI, said, "We are very excited to partner with Dr. Velu and Trivitron. Trivitron has a presence in both value and premium segments, and offers an excellent portfolio of products across India. The medical equipment sector in the country is still nascent and dominated by imports. We believe that India will follow the same evolution trajectory as other emerging markets like China where large, indigenous manufacturers of medical equipment have emerged over the past decade. Trivitron is well positioned to capitalize on this trend with its unparalleled distribution and service infrastructure that is difficult to replicate. High quality manufacturing efforts of Trivitron’ssubsidiaries and joint ventureswill allow Trivitron to expand its product portfolio to all segments of the market.” 

Dr. Velu said, “We are excited to have Fidelity as new investors and board members in Trivitron. Fidelity with its vast knowledge in the medical devices space in China, USA, and Europe will be able to add substantial value to Trivitron in becoming a global player in the imaging and lab diagnostics segments.Fidelity’s long-standing experience in China would also help us in making in-roads in the value segment.I am certain that Fidelity’s guidance would be invaluable in helping Trivitron implement its strong growth plan.”

Trivitron aims to close FY2012-13 with pro-forma gross revenues in excess of INR 700 crores through organic and inorganic routes enabled through this investment round. 

Kotak Mahindra Capital Company (KMCC), the investment banking arm of Kotak Mahindra Bank, was the exclusive advisor to Trivitron on the transaction. Amarchand &Mangaldas& Suresh A. Shroff& Co. acted as the company’s legal counsel. 

About Fidelity Growth Partners 

India Fidelity Growth Partners India (FGPI) is the India-focused private equity arm of Fidelity Worldwide Investment, focused on cross-sector growth capital investing. FGPI seeks to invest in high-quality, high-growth companies in India across a broad range of sectors with typical investment sizes ranging from $10 million to $50 million. FGPI is committed to making the companies it invests in leaders in their industries through access to patient capital with a long term investment mindset, a powerful network of resources and a team of investment professionals with a proven track record of success. Fidelity, Fidelity Worldwide Investment and Fidelity Growth Partners India are trademarks of FIL Limited.

Media contact person: 
Mr Arijit Sengupta
Direct: +91 22 6655 4057
Mob: +91 98203 40485
Email: arijit.sengupta@fil.com 

About Trivitron Healthcare Private Limited 

Established in the year 1997, Trivitron is the largest Indian multinational in medical technology with group revenues of approx.INR500 crores in FY2011-12. Headquartered in Chennai, Trivitron’s presencein India spans 20 offices, with 10 offices in other international locations including South Asia, South East Asia, Middle East and Africa. The company has over 1000 employees. Trivitron offers a value chain of end-to-end solutions in medical technology. Trivitron’s aim is to become the most admired global medical technology player through innovation, comprehensive product solutions and world class customer service and support. For further information logon to www.trivitron.com.

Media contact person
AasiyaShaikh
Mobile: +91 9833503994
Email:aasiya.shaikh@adfactorspr.com 

About KotakMahindra Capital Company Limited (Kotak Investment Banking)  

Kotak Mahindra Capital Company Limited (Kotak Investment Banking) is a leading full-service investment bank in India offering the complete range of capital market and advisory solutions to leading Indian and multinational corporations across diverse sectors. Our services include Equity and Debt Capital Market Issuances, M&A Advisory, Private Equity Advisory, Structured Finance Services and Infrastructure Advisory & Fund Mobilization. KMCC is a subsidiary of Kotak Mahindra Bank Limited, one of India's leading banking and financial services organizations with a consolidated net worth of Rs 13,943crore (approx US$ 2.6 billion) as on September 30, 2012. 

For more information, please visit http://investmentbank.kotak.com/ 

Media contact person
Phiroza Choksi 
Kotak Investment Banking
Mobile: +91 9820363681 
Email:phiroza.choksi@kotak.com

Popular posts from this blog

VC Interview: Shailendra Singh of Sequoia Capital India

In a recent interview to Venture Intelligence, Shailendra Singh discussed some of the firm’s newer investments in the early stage segment including in the online payments space, the progress at a few existing portfolio companies and the active role the firm is playing in helping its portfolio companies scale and succeed in India and globally. Prior to joining the firm in 2006, Singh was a strategy consultant at Bain & Company in New York and before that, an entrepreneur in the digital media industry. Venture Intelligence: How does Sequoia go about identifying potential early stage investments in India? Is there anything different you are doing today than, say, a couple of years back? Shailendra Singh: There is a lot more focus on technology investing and early stage investing. In general, as you might remember a few years ago, we were doing primarily growth investing but in the past 18-odd months, we have had a very strong focus on early stage and that’s continuing. In terms

ChrysCapital, Motilal Oswal PE & Sequoia named PE-VC Firms of the Decade

Press Release ChrysCapital, Motilal Oswal Private Equity and Sequoia Capital India have been named the top Private Equity & Venture Capital investors in India during the last decade, as part of Venture Intelligence’s APEX Awards. The Venture Intelligence “Awards for Private Equity Excellence” (APEX) is dedicated to celebrating the best that the Indian Private Equity & Venture Capital industry has to offer.  While ChrysCapital won the “Private Equity Investor of the Decade” award, Motilal Oswal Private Equity was feted as India’s “Growth Capital Investor of the Decade”. The Indian arm of the storied Silicon Valley VC firm, Sequoia Capital, was named the country’s “Venture Capital Investor of the Decade”. The APEX Awardees are selected based on both Self Nomination by the participating PE-VC firms as well as "crowd sourced" nominations and voting from the Limited Partner, PE-VC and advisory communities. (The main criteria were Exit Track Record, New Fund Raises & Fo

Ambit tops League Table for Transaction Advisors to Private Equity deals in 2019

Ambit Corporate Finance topped the Venture Intelligence League Table for Transaction Advisor to Private Equity Transactions for the year 2019. Ambit advised PE deals worth $2.4 Billion (across 4 qualifying transactions) during the period. Citi ($1.1 Billion across 2 deals) and  Avendus  ($969 million across 12 deals) took the second and third spot. Edelweiss Financial Services ($758 million across 9 deals) and  PwC  ($708 million across 15 deals) completed the top five in 2019.  The  Venture Intelligence League Tables , the first such initiative exclusively tracking transactions involving India-based companies, are based on value of PE and M&A transactions advised by Financial and Legal Advisory firms. Ambit Corporate Finance advised the $1.9 Billion buyout of Pipeline Infrastructure from Reliance Industries   by Brookfield Asset Management  and the IFC and I Squared Capital-backed   Cube Highways' acquisition of Delhi-Agra Toll Road from Reliance Infrastructu

Jio deals help PE investments climb 12% in H1'20 to $18.8 B

Press Release With Reliance Industries' communications unit Jio Platforms attracting 51% of the investment value, Private Equity-Venture Capital (PE-VC) investments in India rose 12% during the first 6 months of 2020 to $18.8 Billion (across 341 deals), shows data from  Venture Intelligence , a research service focused on private company financials, transactions and their valuations. Investments totaling over $9.5 Billion in Jio by a troop of global private equity firms, following social media giant Facebook's $5.7 Billion mid April investment in the company, helped overall PE-VC investments better the $16.8 Billion (across 503 transactions) invested during the same period in 2019. (Note: These figures include Venture Capital investments, but exclude PE investments in Real Estate).   Jio Platforms' $9.5 Billion Private Equity haul (excluding Facebook’s strategic investment) was led by Middle Eastern and American investors with KKR, Saudi Arabia's Public Invest

Inventus, Sixth Sense, Blume & Norwest win Apex'20 Venture Capital Awards

Inventus Capital Partners, Sixth Sense Ventures, Blume Ventures and Norwest Venture Partners were voted the top Venture Capital investors in India during 2019. The Venture Intelligence “Awards for Private Equity Excellence” (APEX) is dedicated to celebrating the best that the Indian Private Equity & Venture Capital industry has to offer. Other 2019 winners in the VC segment included  Axilor Ventures which was voted   the  Accelerator of the Year for the second year running, 3one4 Capital (VC Fund Raise of the Year) and Innoven Capital (Venture Debt firm of the Year). The APEX Awardees are selected based on both Self Nomination by the participating PE-VC firms as well as "crowd sourced" nominations and voting from the Limited Partner, PE-VC and advisory communities. (The main criteria are Exit Track Record, New Fund Raises & Follow-on Funding Rounds for Portfolio Companies).    " It is an honour to be recognised by entrepreneurs and investors as